Sign In
Buy R
$260.38
+2.32 (+0.90%)
At Close: Jun 03, 2026
Ryder Announces CEO Succession Plan
06:55am, Friday, 12'th Dec 2025
MIAMI--(BUSINESS WIRE)--Ryder System, Inc. (NYSE: R) announces Chairman and Chief Executive Officer (CEO) Robert E. Sanchez, 60, will retire on March 31, 2026. As part of the succession plan approved
Zomedica Announces Collaboration with Prime Video as Assisi Loop(R) Products Appear in New Holiday Film Merv
06:30am, Thursday, 11'th Dec 2025
The collaboration highlights Zomedica's commitment to expanding pet wellness education as Assisi Loop technology is featured in the highly anticipated movie Merv now available on Prime Video ANN ARBOR
Momentum continues to build for Company as series of clinical milestones are met, design choices cement differentiation from competition, and timeline comes into focus White Bear Lake, Minnesota--(New
Wellgistics Health Announces Launch of Diabetes Drug Brenzavvy(R) to Wellgistics Pharmacy Network
07:40am, Monday, 08'th Dec 2025
Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are uninsured and underinsured and whose out-of-pocket costs exceed Brenzavvy's cash
Ryder System Strengthens Southeast Network With McDonough Expansion
10:21am, Friday, 05'th Dec 2025
R expands its Southeast footprint with a new McDonough facility, boosting tech-enabled fleet services amid rising regional logistics demand.
Ryder System, Inc. (R) Presents at Goldman Sachs Industrials and Materials Conference 2025 Transcript
03:08pm, Thursday, 04'th Dec 2025
Ryder System, Inc. (R) Presents at Goldman Sachs Industrials and Materials Conference 2025 Transcript
Tenon Medical Announces Successful Completion of Initial Cases with New SImmetry(R)+ SI Joint Fusion System
08:30am, Thursday, 04'th Dec 2025
~ Procedures Completed in Various Spine Centers of Excellence Throughout the Country Including Florida, Arizona, Ohio, and Texas ~ ~ SImmetry+ combines 3D-printed titanium implants, a robust joint dec
Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient
08:00am, Thursday, 04'th Dec 2025
Event to Take Place December 11th at 4:30 P.M. ET White Bear Lake, Minnesota--(Newsfile Corp. - December 4, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing he
Ryder Accelerates Southeast Expansion with New Truck Rental and Maintenance Facility in McDonough, Georgia
06:55am, Thursday, 04'th Dec 2025
MIAMI--(BUSINESS WIRE)--Ryder System, Inc. (NYSE: R) is expanding its presence in the Southeast with the opening of a new 20,000 square feet full-service commercial truck rental and maintenance facili
Zomedica Expands TRUFORMA(R) Diagnostic Menu with Launch of Equine Progesterone Assay
06:30am, Thursday, 04'th Dec 2025
Newest assay expands TRUFORMA market opportunity by building on endocrinology foundation to address reproductive health in the equine segment ANN ARBOR, MI / ACCESS Newswire / December 4, 2025 / Zomed
Edgestream Partners L.P. Buys New Stake in Ryder System, Inc. $R
04:30am, Wednesday, 03'rd Dec 2025
Edgestream Partners L.P. bought a new position in shares of Ryder System, Inc. (NYSE: R) during the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional inve
Here's Why Investors Should Give Ryder System Stock a Miss Now
11:10am, Tuesday, 02'nd Dec 2025
R's rising operating costs, weaker earnings estimates and soft share performance highlight mounting pressures for the company.
StimCell Energetics Inc. Announces Study into eBalance(R) Device's Impact on Neuronal Mitochondrial Function
09:15am, Tuesday, 02'nd Dec 2025
VANCOUVER, BC / ACCESS Newswire / December 2, 2025 / StimCell Energetics Inc. (OTCQB:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance wellness, anti-aging, a
- New Composition of Matter Intellectual Property ("IP") Filing Centered on First-in-Class, Fully Synthetically Manufactured Halneuron®- - New Synthetic Process to be Used for Phase 3 Development Pro
Ensysce Biosciences Announces Broader Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology
08:00am, Tuesday, 02'nd Dec 2025
~ New U.S. Patent Extends Protection Through 2042 ~ ~ Patent Allowance Secures Highest Level of Intellectual Property Protection for MPAR® ~ SAN DIEGO, CA / ACCESS Newswire / December 2, 2025 / Ensys
